Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIDIABETIC AGENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alberti, KGMM
      Treating type 2 diabetes - today's targets, tomorrow's goals

      DIABETES OBESITY & METABOLISM
    2. Scheen, AJ
      Thiazolidinediones and liver toxicity

      DIABETES & METABOLISM
    3. Brown, JB; Nichols, GA; Glauber, HS; Bakst, AW; Schaeffer, M; Kelleher, CC
      Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    4. Halas, CJ
      Nateglinide

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    5. Yu, EH; Guo, HR; Wu, TJ
      Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients

      DIABETIC MEDICINE
    6. Malamas, MS; Sredy, J; McCaleb, M; Gunawan, I; Mihan, B; Sullivan, D
      Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    7. Holl, RW; Wabitsch, M; Heinze, E
      Type-2-diabetes in children and adolescents

      MONATSSCHRIFT KINDERHEILKUNDE
    8. Culy, CR; Jarvis, B
      Repaglinide - A review of its therapeutic use in type 2 diabetes mellitus

      DRUGS
    9. Arakawa, K; Ishihara, T; Oku, A; Nawano, M; Ueta, K; Kitamura, K; Matsumoto, M; Saito, A
      Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na+-glucose cotransporter inhibitor T-1095

      BRITISH JOURNAL OF PHARMACOLOGY
    10. Bozdag-Dundar, O; Waheed, A; Verspohl, EJ; Ertan, R
      Synthesis and hypoglycemic activity of some new flavone derivatives - 4th Communication: 6-Flavonyl-2,4-thiazolidinediones

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    11. Kipnes, MS; Krosnick, A; Rendell, MS; Egan, JW; Mathisen, AL; Schneider, RL
      Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study

      AMERICAN JOURNAL OF MEDICINE
    12. Chu-Moyer, MY
      Patent focus on antidiabetic agents: September 1999-February 2000

      EXPERT OPINION ON THERAPEUTIC PATENTS
    13. Rami, HK; Smith, SA
      Synthetic ligands for PPAR gamma - review of patent literature 1994-1999

      EXPERT OPINION ON THERAPEUTIC PATENTS
    14. Wood, HB; Black, R; Salituro, G; Szalkowski, D; Li, ZH; Zhang, Y; Moller, DE; Zhang, B; Jones, AB
      The basal SAR of a novel insulin receptor activator

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Hanefeld, M; Goke, B
      Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    16. Berger, J; Patel, HV; Woods, J; Hayes, NS; Parent, SA; Clemas, J; Leibowitz, MD; Elbrecht, A; Rachubinski, RA; Capone, JP; Moller, DE
      A PPAR gamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    17. Malamas, MS; Sredy, J; Gunawan, I; Mihan, B; Sawicki, DR; Seestaller, L; Sullivan, D; Flam, BR
      New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties

      JOURNAL OF MEDICINAL CHEMISTRY
    18. Chehade, JM; Mooradian, AD
      A rational approach to drug therapy of type 2 diabetes mellitus

      DRUGS
    19. Bozdag, O; Verspohl, EJ; Ertan, R
      Synthesis and hypoglycemic activity of some new flavone derivatives - 3rd communication: 3 '-flavonyl-2,4-thiazolidinediones

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    20. Bozdag, O; Verspohl, EJ; Ertan, R
      Synthesis and hypoglycemic activity of some new flavone derivatives - 2nd communication: 4 '-flavonyl-2,4-thiazolidinediones

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    21. Malaisse, WJ
      Physiology, pathology and pharmacology of insulin secretion

      ACTA CLINICA BELGICA
    22. Shinkai, H
      Recent developments in oral hypoglycemic agents

      DRUG DISCOVERY TODAY
    23. Ginsberg, H; Plutzky, J; Sobel, BE
      A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering

      JOURNAL OF CARDIOVASCULAR RISK
    24. Kulkarni, SS; Gediya, LK; Kulkarni, VM
      Three-dimensional quantitative structure activity relationships (3-D-QSAR)of antihyperglycemic agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    25. Haigh, D; Allen, G; Birrell, HC; Buckle, DR; Cantello, BCC; Eggleston, DS; Haltiwanger, RC; Holder, JC; Lister, CA; Pinto, IL; Rami, HK; Sime, JT; Smith, SA; Sweeney, JD
      Non-thiazolidinedione antihyperglycaemic agents. Part 3: The effects of stereochemistry on the potency of alpha-methoxy-beta-phenylpropanoic acids

      BIOORGANIC & MEDICINAL CHEMISTRY
    26. Gaupp, S; Effenberger, F
      Stereoselective follow-up reactions of (S)-2-sulfanyl nitriles

      TETRAHEDRON-ASYMMETRY
    27. Haigh, D; Birrell, HC; Cantello, BCC; Hindley, RM; Ramaswamy, A; Rami, HK; Stevens, NC
      Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of ( plus /-)-, (R)-(+)- and (S)-(-)-enantiomers of 2-oxy-3-arylpropanoic acids

      TETRAHEDRON-ASYMMETRY
    28. Haigh, D; Birrell, HC; Cantello, BCC; Eggleston, DS; Haltiwanger, RC; Hingley, RM; Ramaswamy, A; Stevens, NC
      Non-thiazolidinedione antihyperglycaemic agents. Part 5: Asymmetric aldol synthesis of (S)-(-)-2-oxy-3-arylpropanoic acids

      TETRAHEDRON-ASYMMETRY
    29. Malaisse, WJ
      Mechanism of action of a new class of insulin secretagogues

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    30. Davies, GF; Khandelwal, RL; Roesler, WJ
      Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    31. Emilien, G; Maloteaux, JM; Ponchon, M
      Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment

      PHARMACOLOGY & THERAPEUTICS
    32. Howlett, HCS; Bailey, CJ
      A risk-benefit assessment of metformin in type 2 diabetes mellitus

      DRUG SAFETY
    33. Hongu, M; Saito, K; Tsujihara, K
      Solid-liquid phase transfer catalyzed novel glycosylation reaction of phenols

      SYNTHETIC COMMUNICATIONS
    34. Lohray, BB; Bhushan, V; Reddy, AS; Rao, PB; Reddy, NJ; Harikishore, P; Haritha, N; Vikramadityan, RK; Chakrabarti, R; Rajagopalan, R; Katneni, K
      Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones

      JOURNAL OF MEDICINAL CHEMISTRY
    35. Reul, BA; Amin, SS; Buchet, JP; Ongemba, LN; Crans, DC; Brichard, SM
      Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats

      BRITISH JOURNAL OF PHARMACOLOGY
    36. Jajoo, HK; Mamidi, RNVS; Vakkalanka, SVS; Sathyavageeswaran, S; Katneni, K; Ayalasomayajula, PS; Rao, BP; Lohray, BB; Subramaniam, S
      Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    37. Osanai, H; Toki, Y; Nakashima, Y; Okumura, K; Ito, T; Hayakawa, T
      Reduction of vascular tone by introduction of troglitazone to the canine coronary artery

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    38. DeFronzo, RA
      Pharmacologic therapy for type 2 diabetes mellitus

      ANNALS OF INTERNAL MEDICINE
    39. CHEN C
      TROGLITAZONE - AN ANTIDIABETIC AGENT (REPRINTED)

      American journal of health-system pharmacy
    40. REDDY KA; LOHRAY BB; BHUSHAN V; REDDY AS; KISHORE PH; RAO VV; SAIBABA V; BAJJI AC; RAJESH BM; REDDY KV; CHAKRABARTI R; RAJAGOPALAN R
      NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - PART-2 - ANTIOXIDANT MOIETY AS STRUCTURAL MOTIF

      Bioorganic & medicinal chemistry letters
    41. SAWICKI PT; BERGER M
      PHARMACOLOGICAL TREATMENT OF DIABETIC-PATIENTS WITH CARDIOVASCULAR COMPLICATIONS

      Journal of internal medicine
    42. Pastore, L; Morviducci, L; Merante, D; Coppini, A; Mellozzi, M; D'Adamo, M; Sbraccia, P; Giaccari, A; Tamburrano, G
      Combined glibenclamide plus metformin improves insulin sensitivity in non-obese Type 2 diabetic patients

      DIABETES NUTRITION & METABOLISM
    43. YOUNG PW; BUCKLE DR; CANTELLO BCC; CHAPMAN H; CLAPHAM JC; COYLE PJ; HAIGH D; HINDLEY RM; HOLDER JC; KALLENDER H; LATTER AJ; LAWRIE KWM; MOSSAKOWSKA D; MURPHY GJ; COX LR; SMITH SA
      IDENTIFICATION OF HIGH-AFFINITY BINDING-SITES FOR THE INSULIN SENSITIZER ROSIGLITAZONE (BRL-49653) IN RODENT AND HUMAN ADIPOCYTES USING A RADIOIODINATED LIGAND FOR PEROXISOMAL PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA

      The Journal of pharmacology and experimental therapeutics
    44. WROBEL J; LI ZN; DIETRICH A; MCCALEB M; MIHAN B; SREDY J; SULLIVAN D
      NOVEL -PROPYNYL)-5-(ARYLSULFONYL)THIAZOLIDINE-2,4-DIONES AS ANTIHYPERGLYCEMIC AGENTS

      Journal of medicinal chemistry
    45. SHINKAI H; ONOGI S; TANAKA M; SHIBATA T; IWAO M; WAKITANI K; UCHIDA I
      ISOXAZOLIDINE-3,5-DIONE AND NONCYCLIC 1,3-DICARBONYL COMPOUNDS AS HYPOGLYCEMIC AGENTS

      Journal of medicinal chemistry
    46. LOHRAY BB; BHUSAN V; RAO BP; MEDHAVAN GR; MURALI N; RAO KN; REDDY AK; RAJESH BM; REDDY PG; CHAKRABARTI R; VIKRAMADITHYAN RK; RAJAGOPALAN R; MAMIDI RNVS; JAJOO HK; SUBRAMANIAN S
      NOVEL EUGLYCEMIC AND HYPOLIPIDEMIC AGENTS - 1

      Journal of medicinal chemistry
    47. Henke, BR; Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Orband-Miller, LA; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM
      N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

      JOURNAL OF MEDICINAL CHEMISTRY
    48. Collins, JL; Blanchard, SG; Boswell, GE; Charifson, PS; Cobb, JE; Henke, BR; Hull-Ryde, EA; Kazmierski, WM; Lake, DH; Leesnitzer, LM; Lehmann, J; Lenhard, JM; Orband-Miller, LA; Gray-Nunez, Y; Parks, DJ; Plunkett, KD; Tong, WQ
      N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety

      JOURNAL OF MEDICINAL CHEMISTRY
    49. ARAKAWA K; ISHIHARA T; AOTO M; INAMASU M; SAITO A; IKEZAWA K
      ACTIONS OF NOVEL ANTIDIABETIC THIAZOLIDINEDIONE, T-174, IN ANIMAL-MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM) AND IN CULTUREDMUSCLE-CELLS

      British Journal of Pharmacology
    50. UEDA N; NOMURA Y; MUTA Y; MATSUZAKI Y; HAYASHIBE M; INO Y; SUZUKI S; KURUMI M
      PHARMACOLOGICAL AND PHARMACOKINETIC STUDIES OF THE NEWLY SYNTHESIZED THIAZOLIDINEDIONE DERIVATIVE ROPANECARBONYLAMINO)BENZYL)-THIAZOLIDINE-2,4-DIONE

      Arzneimittel-Forschung
    51. HIRSCH IB
      APPROACH TO THE PATIENT WITH DIABETES UNDERGOING A VASCULAR OR INTERVENTIONAL PROCEDURE

      Journal of vascular and interventional radiology
    52. LOHRAY BB; BHUSHAN V; RAO PB; MADHAVAN GR; MURALI N; RAO KN; REDDY KA; RAJESH BM; REDDY PG; CHAKRABARTI R; RAJAGOPALAN R
      NOVEL INDOLE CONTAINING THIAZOLIDINEDIONE DERIVATIVES AS POTENT EUGLYCEMIC AND HYPOLIPEMIC AGENTS

      Bioorganic & medicinal chemistry letters
    53. SILVA JE; RABELO R
      REGULATION OF THE UNCOUPLING PROTEIN GENE-EXPRESSION

      European journal of endocrinology
    54. HUFF BE; LEFFELMAN CL; LETOURNEAU ME; SULLIVAN KA; WARD JA; STILLE JR
      SYNTHETIC APPROACHES TO BENZOFURAN CONTAINING INSULIN SENSITIVITY ENHANCER COMPOUNDS FOR TREATMENT OF TYPE-II DIABETES

      Heterocycles
    55. YOSHIOKA T; FUJITA T
      STUDIES ON COMPOUNDS WITH ANTIOXIDANT ACTIVITY - DEVELOPMENT OF HYPOGLYCEMIC AGENTS, TROGLITAZONE (CS-045)

      Yakugaku zasshi
    56. IGARASHI M; TAKEDA Y; ISHIBASHI N; TAKAHASHI K; MORI S; TOMINAGA M; SAITO Y
      PIOGLITAZONE REDUCES SMOOTH-MUSCLE CELL-DENSITY OF RAT CAROTID ARTERIAL INTIMA INDUCED BY BALLOON CATHETERIZATION

      Hormone and Metabolic Research
    57. ARAKAWA K; INAMASU M; MATSUMOTO M; OKUMURA K; YASUDA K; AKATSUKA H; KAWANAMI S; WATANABE A; HOMMA K; SAIGA Y; OZEKI M; IIJIMA I
      NOVEL BENZOXAZOLE 2,4-THIAZOLIDINEDIONES AS POTENT HYPOGLYCEMIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Chemical and Pharmaceutical Bulletin
    58. MARK M; GRELL W
      HYPOGLYCEMIC EFFECTS OF THE NOVEL ANTIDIABETIC AGENT REPAGLINIDE IN RATS AND DOGS

      British Journal of Pharmacology
    59. KIYOTA Y; KONDO T; MAESHIBA Y; HASHIMOTO A; YAMASHITA KJ; YOSHIMURA Y; MOTOHASHI M; TANAYAMA S
      STUDIES ON THE METABOLISM OF THE NEW ANTIDIABETIC AGENT PIOGLITAZONE - IDENTIFICATION OF METABOLITES IN RATS AND DOGS

      Arzneimittel-Forschung
    60. BRESSLER R; JOHNSON DG
      PHARMACOLOGICAL REGULATION OF BLOOD-GLUCOSE LEVELS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      Archives of internal medicine
    61. YAMASHITA K; MURAKAMI H; OKUDA T; MOTOHASHI M
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PIOGLITAZONEAND ITS METABOLITES IN HUMAN SERUM AND URINE

      Journal of chromatography B. Biomedical applications
    62. TURNER NC
      NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF INSULIN-RESISTANCE AND NIDDM

      Drug discovery today
    63. LEMBERGER T; DESVERGNE B; WAHLI W
      PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS - A NUCLEAR RECEPTOR SIGNALING PATHWAY IN LIPID PHYSIOLOGY

      Annual review of cell and developmental biology
    64. MARTIN AE; MONTGOMERY PA
      ACARBOSE - AN ALPHA-GLUCOSIDASE INHIBITOR

      American journal of health-system pharmacy
    65. BUCKLE DR; CANTELLO BCC; CAWTHORNE MA; COYLE PJ; DEAN DK; FALLER A; HAIGH D; HINDLEY RM; JEFCOTT LJ; LISTER CA; PINTO IL; RAMI HK; SMITH DG; SMITH SA
      NON THIAZOLIDINEDIONE ANTIHYPERGLYCEMIC AGENTS .1. ALPHA-HETEROATOM SUBSTITUTED BETA-PHENYLPROPANOIC ACIDS

      Bioorganic & medicinal chemistry letters
    66. PEULER JD; PHARE SM; IANNUCCI AR; HODOREK MJ
      DIFFERENTIAL INHIBITORY EFFECTS OF ANTIDIABETIC DRUGS ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION

      American journal of hypertension
    67. MELANDER A
      ORAL ANTIDIABETIC DRUGS - AN OVERVIEW

      Diabetic medicine
    68. PISU E; MARENA S; ARCARI R; MONTEGROSSO G; GRISERI P; DEMICHIELI F; PAGANO G
      DEPRESSED INSULIN-SECRETION IN RESPONSE TO DIFFERENT STIMULI IS A FEATURE OF SECONDARY FAILURE IN NORMAL-WEIGHT NON-INSULIN-DEPENDENT DIABETICS ON SULFONYLUREAS

      Diabetes, nutrition & metabolism
    69. LAMBERTH C; BLARER S
      CONCISE APPROACH TO 1-THIAHYDANTOCIDIN

      Synthetic communications
    70. HULIN B; NEWTON LS; LEWIS DM; GENEREUX PE; GIBBS EM; CLARK DA
      HYPOGLYCEMIC ACTIVITY OF A SERIES OF ALPHA-ALKYLTHIO AND ALPHA-ALKOXYCARBOXYLIC-ACIDS RELATED TO CIGLITAZONE

      Journal of medicinal chemistry
    71. JOHNSON RA; MARSHALL VP; LI GP; SIH JC; CIALDELLA JI; LIGGETT WF; NIDY EG
      MICROBIOLOGICAL N-DEOXYGENATION AND C-OXYGENATION OF PIOGLITAZONE-N-OXIDE IN A SINGLE FERMENTATION

      Journal of antibiotics
    72. PEREZROLDAN F; AGUIRRE A; BANARES R; CASADO M; GONZALEZASANZA C; ALVAREZ E; CLEMENTE G
      CHOLESTATIC HEPATITIS INDUCED BY GLYBENCL AMIDE IN A PATIENT WITH HEPATITIS-C VIRUS

      Revista espanola de enfermedades digestivas
    73. FORMAN BM; TONTONOZ P; CHEN J; BRUN RP; SPIEGELMAN BM; EVANS RM
      15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA

      Cell
    74. KEES KL; CAGGIANO TJ; STEINER KE; FITZGERALD JJ; KATES MJ; CHRISTOS TE; KULISHOFF JM; MOORE RD; MCCALEB ML
      STUDIES ON NEW ACIDIC AZOLES AS GLUCOSE-LOWERING AGENTS IN OBESE, DIABETIC DB DB MICE/

      Journal of medicinal chemistry
    75. HEITZMANN T; NEIDLEIN R; FREUND P; REIFF K; STREIN K
      DOSE PROPORTIONALITY STUDIES OF NOVEL THIAZOLIDINEDIONE DERIVATIVES AS POTENT ANTIDIABETIC AGENTS IN MICE

      Arzneimittel-Forschung
    76. DENANTEUIL G; HERVE Y; DUHAULT J; ESPINAL J; BOULANGER M; RAVEL D
      EUGLYCEMIC AND BIOLOGICAL-ACTIVITIES OF NOVEL THIAZOLIDINE-2,4-DIONE DERIVATIVES

      Arzneimittel-Forschung
    77. HEITZMANN T; NEIDLEIN R; FREUND P; REIFF K; STREIN K
      PHARMACOKINETICS OF SOME NEW ORAL BLOOD GLUCOSE-LOWERING AGENTS IN DOGS

      Arzneimittel-Forschung
    78. CANTELLO BCC; CAWTHORNE MA; HAIGH D; HINDLEY RM; SMITH SA; THURLBY PL
      THE SYNTHESIS OF BRL-49653 - A NOVEL AND POTENT ANTIHYPERGLYCEMIC AGENT

      Bioorganic & medicinal chemistry letters
    79. CANTELLO BCC; CAWTHORNE MA; COTTAM GP; DUFF PT; HAIGH D; KINDLEY RM; LISTER CA; SMITH SA; THURLBY PL
      OCYCLYLAMINO)ALKOXY]BENZYL]-2,4-THIAZOLIDINEDIONES AS POTENT ANTIHYPERGLYCEMIC AGENTS

      Journal of medicinal chemistry
    80. YAMAGUCHI T; MIURA K; USUI T; UNNO R; MATSUMOTO Y; FUKUSHIMA M; MIZUNO K; KONDO Y; BABA Y; KURONO M
      SYNTHESIS AND ALDOSE REDUCTASE INHIBITORY ACTIVITY OF O[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONES

      Arzneimittel-Forschung
    81. SCHEEN AJ; LEFEBVRE PJ
      PHARMACOLOGICAL TREATMENT OF THE OBESE-DIABETIC PATIENT

      Diabete et metabolisme
    82. ELLINGBOE JW; LOMBARDO LJ; ALESSI TR; NGUYEN TT; GUZZO F; GUINOSSO CJ; BULLINGTON J; BROWNE ENC; BAGLI JF; WRENN J; STEINER K; MCCALEB ML
      ANTIHYPERGLYCEMIC ACTIVITY OF NOVEL NAPHTHALENYL 3H-1,2,3,5-OXATHIADIAZOLE 2-OXIDES

      Journal of medicinal chemistry
    83. GOLDSTEIN SW; MCDERMOTT RE; GIBBS EM; STEVENSON RW
      HYDROXYUREA DERIVATIVES AS HYPOGLYCEMIC AGENTS

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 10:43:42